Clinical Study

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents

Table 1

Changes in overactive bladder symptom scores in 52 patients treated with propiverine hydrochloride.

Baseline4 weeks12 weeks
OABSS 9 . 0 ± 2 . 2 (1) 6 . 2 ± 3 . 3 ** 6 . 3 ± 3 . 3 **

Daytime frequency 0 . 9 ± 0 . 4 0 . 8 ± 0 . 6 0 . 8 ± 0 . 4
Nighttime frequency 2 . 3 ± 0 . 8 1 . 9 ± 0 . 8 * 1 . 9 ± 0 . 9 **
Urgency 3 . 7 ± 0 . 9 2 . 3 ± 1 . 7 ** 2 . 2 ± 1 . 6 **
Urgency incontinence 2 . 2 ± 1 . 6 1 . 2 ± 1 . 6 ** 1 . 4 ± 1 . 6 *

OABSS: overactive bladder symptom score.
(1)Mean ± standard deviation.
* 𝑃 < 0 . 0 1 , ** 𝑃 < 0 . 0 0 1 (versus baseline, paired t-test).